Background illustration for clinical trials search

Paid Clinical Trials Denton

Discover 1,955 paid clinical trials in Denton, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

IHT for Mild Cognitive Impairment

for
Mild Cognitive Impairment, Memory Impairment
Location: Fort Worth TX
Sponsor: University of North Texas Health Science Center

Sex: All

Age: 55 - 70+

Code: NCT05495087

Recruiting

ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Dallas TX, Nashville TN, Denver CO, San Diego CA
Sponsor: Acepodia Biotech, Inc.

Sex: All

Age: 18+

Code: NCT06415487

Phase 1, Recruiting

Follow-up Visit of High Risk Infants

for
Infant, Newborn, Infant, Low Birth Weight,
Location: Dallas TX, Houston TX, Kansas City MO, Albuquerque NM,
Sponsor: NICHD Neonatal Research Network

Sex: All

Age: 1 - 2

Code: NCT00009633

Recruiting

Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation

for
Infusion Reactions
Location: Dallas TX, Fort Worth TX, Oklahoma City OK, Houston TX,
Sponsor: New York Blood Center

Sex: All

Age: 0+

Code: NCT01656603

Phase 2, Recruiting

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

for
Breast Cancer
Location: Dallas TX, Sugar Land TX, Springdale AR, Baton Rouge LA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06103864

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

for
Amblyopia
Location: Fort Worth TX, Oklahoma City OK, Houston TX,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 3 - 13

Code: NCT04378790

Phase 3, Recruiting

ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions

for
Breast Cancer
Location: Dallas TX, Houston TX, Seattle WA
Sponsor: ARTIDIS AG

Sex: All

Age: 18+

Code: NCT06085833

Recruiting

Abatacept in Immune Checkpoint Inhibitor Myocarditis

for
Myocarditis Acute, Cancer
Location: Dallas TX, Kansas City KS, Indianapolis IN,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT05335928

Phase 3, Recruiting

IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)

for
Acute Myeloid Leukemia
Location: Dallas TX, Aurora CO, Columbus OH, Chapel Hill NC
Sponsor: Alice Mims

Sex: All

Age: 18+

Code: NCT05401097

Phase 2, Recruiting

Evaluation of Resection Techniques for Pancreatic Tumors

for
Surgery, Liver Tumor, Pancreas Tumor
Location: Dallas TX
Sponsor: Methodist Health System

Sex: All

Age: 18+

Code: NCT05128890

Recruiting

Tissue Repair Gel in Venous Leg Ulcers in AU/US

for
Venous Leg Ulcer, Venous Ulcer, Venous Stasis Ulcer,
Location: Fort Worth TX, Jacksonville FL, Clinton Twp MI
Sponsor: TR Therapeutics

Sex: All

Age: 18+

Code: NCT06707103

Phase 3, Recruiting

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

for
Rheumatic Joint Disease
Location: Dallas TX, Houston TX, Jackson MS, Kansas City MO,
Sponsor: Duke University

Sex: All

Age: 0 - 21

Code: NCT02418442

Recruiting

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

for
Locally Advanced Breast Cancer, Unresectable Breast Carcinoma,
Location: Dallas TX, San Antonio TX, Kansas City MO, St Louis MO,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06827236

Phase 1, Phase 2, Recruiting

Rett Syndrome Registry

for
Rett Syndrome, Rett Syndrome, Atypical, Genetic Disease,
Location: Dallas TX, Houston TX, St Louis MO, Birmingham AL,
Sponsor: International Rett Syndrome Foundation

Sex: All

Age: 0 - 70+

Code: NCT05432349

Recruiting

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

for
Previously Untreated Relapsed Refractory Acute Myeloid Leukemia
Location: Dallas TX, Fairway KS, Atlanta GA, Chicago IL,
Sponsor: Beat AML, LLC

Sex: All

Age: 18+

Code: NCT03013998

Phase 2, Phase 3, Recruiting

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

for
Mesothelioma, Non Small Cell Lung Cancer,
Location: Dallas TX, Fort Worth TX, Tyler TX, Houston TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT05245500

Phase 1, Recruiting

US National OCS Heart Perfusion (OHP) Registry

for
Heart Transplant
Location: Dallas TX, Boulder CO, Atlanta GA, Lexington KY,
Sponsor: TransMedics

Sex: All

Age: 0+

Code: NCT05915299

Recruiting

Diagnosing Epilepsy To EffeCT Change

for
Epilepsy, Epilepsy (Treatment Refractory)
Location: Dallas TX, Houston TX, St Louis MO, Birmingham AL,
Sponsor: Epiminder America, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07110337

Recruiting

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

for
Lymphoma, Large B-Cell, Diffuse
Location: Dallas TX, Palestine TX, Austin TX, Shreveport LA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06890884

Phase 2, Recruiting

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

for
Depressive Disorder, Major
Location: Fort Worth TX, Wichita Falls TX, Edmond OK, Bellaire TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18 - 70+

Code: NCT06559306

Phase 3, Recruiting